HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyohide Fujimoto Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/20225-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells.
1/2016Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.
10/2011ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyohide Fujimoto Research Topics

Disease

117Neoplasms (Cancer)
05/2024 - 02/2003
84Prostatic Neoplasms (Prostate Cancer)
05/2024 - 06/2003
55Urinary Bladder Neoplasms (Bladder Cancer)
12/2023 - 02/2004
48Carcinoma (Carcinomatosis)
05/2024 - 02/2003
33Non-Muscle Invasive Bladder Neoplasms
05/2024 - 01/2010
28Renal Cell Carcinoma (Grawitz Tumor)
05/2024 - 02/2003
21Neoplasm Metastasis (Metastasis)
01/2023 - 06/2003
13Nocturia
04/2024 - 06/2005
12Polyuria
04/2024 - 06/2005
10Lower Urinary Tract Symptoms
09/2022 - 06/2005
9Overactive Urinary Bladder (Overactive Bladder)
05/2024 - 12/2009
9Inflammation (Inflammations)
12/2023 - 09/2009
7Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2022 - 07/2003
7Adenocarcinoma
12/2020 - 06/2009
6Carcinogenesis
12/2020 - 07/2008
5Infections
03/2024 - 09/2009
5Pain (Aches)
11/2023 - 12/2005
5Pheochromocytoma
09/2023 - 12/2004
5Hypoxia (Hypoxemia)
10/2022 - 03/2011
4Urinary Incontinence
05/2024 - 01/2004
4Hemorrhage
03/2024 - 03/2002
4Ischemia
12/2023 - 11/2020
4Urologic Neoplasms (Urological Cancer)
11/2022 - 05/2020
4Lymphatic Metastasis
09/2022 - 02/2004
4Carcinoma in Situ
05/2022 - 01/2010
4Margins of Excision
10/2019 - 11/2012
4Thrombosis (Thrombus)
01/2018 - 05/2008
3Disease Progression
05/2024 - 01/2021
3Residual Neoplasm
05/2024 - 01/2022
3Neurogenic Urinary Bladder (Bladder, Neurogenic)
05/2024 - 11/2020
3COVID-19
03/2024 - 01/2022
3Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 05/2018
3Cryptorchidism (Undescended Testes)
11/2023 - 01/2020
3Urinary Tract Infections (Urinary Tract Infection)
11/2023 - 10/2012
3Interstitial Cystitis (Interstitial Cystitis, Chronic)
11/2023 - 12/2009
3Sarcoma (Soft Tissue Sarcoma)
03/2023 - 10/2020
3Edema (Dropsy)
01/2022 - 06/2011

Drug/Important Bio-Agent (IBA)

22AcidsIBA
05/2024 - 07/2009
19Prostate-Specific Antigen (Semenogelase)IBA
01/2024 - 06/2003
15Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2009
13Biomarkers (Surrogate Marker)IBA
11/2023 - 05/2014
12Small Interfering RNA (siRNA)IBA
11/2023 - 07/2008
11AndrogensIBA
01/2024 - 12/2003
9Immune Checkpoint InhibitorsIBA
05/2024 - 01/2020
9CytokinesIBA
02/2024 - 03/2006
9Cisplatin (Platino)FDA LinkGeneric
03/2023 - 06/2003
8Docetaxel (Taxotere)FDA Link
01/2024 - 01/2017
8GemcitabineFDA Link
03/2023 - 06/2010
8CreatinineIBA
07/2022 - 11/2004
7PlatinumIBA
05/2024 - 01/2020
7AntibodiesIBA
06/2023 - 12/2004
7protoporphyrin IXIBA
03/2023 - 07/2009
7pembrolizumabIBA
11/2022 - 01/2020
7NitrosaminesIBA
06/2021 - 08/2007
6Hormones (Hormone)IBA
01/2024 - 03/2010
6Sunitinib (Sutent)FDA Link
05/2023 - 06/2012
6Syndecan-1 (Syndecan 1)IBA
05/2020 - 01/2010
5enfortumab vedotinIBA
04/2024 - 09/2022
5Messenger RNA (mRNA)IBA
12/2023 - 06/2019
5Heme Oxygenase-1IBA
03/2023 - 01/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022 - 07/2009
5Iodine-125IBA
01/2019 - 01/2009
4NivolumabIBA
05/2024 - 10/2018
4MicroRNAs (MicroRNA)IBA
11/2023 - 10/2015
4Tamsulosin (Flomax)FDA LinkGeneric
01/2022 - 01/2004
4Peptides (Polypeptides)IBA
01/2021 - 03/2006
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2020 - 05/2011
4Cholinergic Antagonists (Anticholinergics)IBA
01/2020 - 04/2014
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2019 - 01/2010
4Arginine Vasopressin (Argipressin)IBA
05/2014 - 07/2006
4Androgen Antagonists (Antiandrogens)IBA
01/2013 - 01/2004
3CarcinogensIBA
05/2024 - 04/2018
3Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
04/2024 - 05/2014
3Tyrosine Kinase InhibitorsIBA
02/2024 - 03/2010
3CatecholaminesIBA
09/2023 - 07/2011
3Axitinib (AG 013736)IBA
05/2023 - 10/2018
3EnzymesIBA
04/2023 - 01/2018
3C-Reactive ProteinIBA
01/2023 - 05/2008
3RNA (Ribonucleic Acid)IBA
09/2022 - 04/2008
3Claudin-4IBA
06/2022 - 12/2015
3IsoflavonesIBA
06/2022 - 08/2007
3Testosterone (Sustanon)FDA Link
02/2022 - 04/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2011

Therapy/Procedure

66Therapeutics
05/2024 - 02/2003
32Drug Therapy (Chemotherapy)
05/2024 - 06/2003
28Brachytherapy
05/2024 - 01/2009
23Prostatectomy (Retropubic Prostatectomy)
03/2024 - 01/2004
20Cystectomy
03/2024 - 02/2004
19Nephrectomy
03/2024 - 02/2003
16Transurethral Resection of Bladder
05/2024 - 01/2010
15Radiotherapy
09/2022 - 06/2010
11Castration
10/2023 - 03/2010
10Nephroureterectomy
07/2022 - 12/2016
7Oral Administration
06/2021 - 07/2004
6Kidney Transplantation
10/2023 - 01/2018
6Lymph Node Excision (Lymph Node Dissection)
01/2023 - 06/2003
5Orchiectomy (Orchidectomy)
10/2013 - 07/2003
3Immunotherapy
04/2024 - 10/2019
3Renal Dialysis (Hemodialysis)
11/2023 - 02/2003
3Orchiopexy
11/2023 - 01/2020